Back to
Cresset Asset Management, LLC
ASND
Showing 0 of 2 quarters
Position history for
Cresset Asset Management, LLC's holdings in <![CDATA[ASCENDIS PHARMA A/S]]>
No. Cresset Asset Management exited its ASND (<![cdata[ascendis Pharma A/S]]>) position in Q4 2023. Its Q3 2023 13F listed 2,605 shares worth $243,932. Cresset Asset Management first reported ASND in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.